Q3 2011 · 10-Q
Revenue$12.22M$12.22M +34.9% vs Q3 2010+8.5% vs Q2 2011
Net Income-$20.63M-$20.63M N/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.21-$0.21 N/M vs Q3 2010N/M vs Q2 2011
Operating Income-$21,616,000N/M
Operating Cash Flowderived-$25,415,000N/M
Free Cash Flowderived-$25,981,000N/M
Margins · derived
Operating margin-176.9%+1.5 pt vs Q3 2010
Net margin-168.9%−94.4 pt vs Q3 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $12.22M | $9.06M |
| Net Income | -$20.63M | -$6.75M |
| EPS Diluted | -$0.21 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR